Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT03573999 : Effect of Mannitol 20% Versus Hypertonic Saline 7.5% in Brain Metabolism and Oxygenation
PhasePhase 4
AgesMin: 18 Years Max: 75 Years
Eligibility
Inclusion Criteria:

- Adult patients aged between 18 and 75 years

- ASA Physical status 1 to 3

- Elective or semi-elective supratentorial craniotomy

- Signed informed consent

Exclusion Criteria:

- Craniotomy for suprasellar pathologies

- Re-craniotomy at the same site

- Perioperative sodium disorders (Na <130 mEq/L or >150 mEq/L)

- Administration of intravenous mannitol or hypertonic saline 7.5% 24 hours or less
before the surgery

- Preoperative obstructive hydrocephalus

- Congestive heart failure

- Renal failure
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT03573999      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740